… There’s been mostly good news on the coronavirus vaccine front. Two separate vaccine makers (Moderna and Pfizer) say their vaccines are about 95% effective with no major safety concerns, and Pfizer has applied to the Food and Drug Administration for emergency authorization. The hope is that many people can begin to get immunized by April, according to the National Institutes of Health Director Dr. Francis Collins.
A vaccine at this high efficiency could be a game changer.
A vaccine, however, isn’t worth much if Americans won’t actually get it. A look at the polling trendline on a coronavirus vaccine and history suggests it is, again, mostly good news when it comes to people being willing to get it. CONTINUED
Harry Enten, CNN